UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C., 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date Of Report (Date Of Earliest Event Reported): March 30, 2010
![[tnus8k033110apg001.jpg]](https://capedge.com/proxy/8-K/0001469709-10-000036/tnus8k033110apg001.jpg)
Total Nutraceutical Solutions, Inc.
(Exact Name of Registrant as Specified in its Charter)
Commission File Number: 000-52864
| | |
NEVADA | | 26-0561199 |
(State or Other Jurisdiction of | | (I.R.S. Employer |
Incorporation or Organization) | | Identification No.) |
PO Box 910, Stevenson, WA 98648
(Address of Principal Executive Offices, Including Zip Code)
(509) 427-5132
(Registrant’s Telephone Number, Including Area Code)
____________
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act(17CFR240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act(17CFR240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act(17CFR240.13e-4(c))
Items to be Included in this Report
| |
Item 7.01. | Regulation FD Disclosure. |
On March 30, 2010, TNS issued a press release announcing that it has entered into a revenue sharing agreement to undertake a direct mail marketing program of a proprietary private label compound developed and manufactured by the company for joint pain and inflammation. The parties to the agreement are: 1) AMC, LLC (“AMC”) based in Los Angeles, California; 2) Delta Group Investments Limited (“DGI”), based in Hong Kong and 3) Total Nutraceutical Solutions, Inc. (“TNS”) based in Stevenson, Washington.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference in its entirety.
| |
Item 9.01. | Exhibits. Financial Statements, and Exhibits |
| | |
| 99.1 | Press release issued on March 30, 2010 by the Company.* |
* This exhibit is intended to be furnished and shall not be deemed "filed” for purposes of the Securities Exchange Act of 1934, as amended.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Total Nutraceutical Solutions, Inc.
(Registrant)
/s/ Marvin S. Hausman, M.D.
Marvin S. Hausman, M.D.
Chief Executive Officer
